1. 18.i. Listedness/Expectedness Assessment—Introduction | Pharmacovigilance (2019). https://allaboutpharmacovigilance.org/18-i-listedness-expectedness-assessment-introduction/. Accessed 20 Sept 2023
2. Allen EN, Chandler CI, Mandimika N, Leisegang C, Barnes K (2018) Eliciting adverse effects data from participants in clinical trials. Cochrane Database Syst Rev 1:MR000039. https://doi.org/10.1002/14651858.MR000039.pub2
3. Argus. https://www.oracle.com/in/life-sciences/pharmacovigilance/argus-safety-case-management/. Accessed 20 September 2023
4. Asiamah M, Akuffo KO, Nortey P, Donkor N, Danso-Appiah A (2022) Spontaneous reporting of adverse drug reaction among health professionals in Ghana. Arch Publ Health 80(1):1–1. https://doi.org/10.1186/s13690-021-00783-1
5. Assessing Labelling, Listedness, Expectedness in Pharmacovigilance: Differences & Methodology used in assessment. https://www.linkedin.com/pulse/assessing-labelling-listedness-expectedness-used-and-vigilance/?trackingId=Kjertg2oT8aD0EmiNJ3aug%3D%3D. Accessed 20 Sept 2023